drugset / Trial / NCT06717945
The Efficacy and Safety of Remimazolam Besylate for Cardiac Anesthesia
RandomizedParallel-groupTriple-blindTreatment
Summary
The evidence on the practice of remimazolam besylate during cardiac anesthesia is scarce. This study investigates the efficacy and safety of remimazolam besylate general induction and maintenance during cardiac surgery.
Timeline
- Start
- 2025-01
- Primary completion
- 2025-05
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propofol | Small molecule | 1 mg/kg | — |
| Comparator | Propofol | Small molecule | 1.5 mg/kg | — |
| Subject | Remimazolam | Small molecule | 1 mg/kg | — |
Indications
No indication recorded.